Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patriarca

Showing results (871-880 of 1,012) with videos related to

Pageof 102
Sort By:
Cytokine|September 18, 2020
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infectionCamila Ferreira Marcon, Paula Tatiana Mutão Ferreira, Priscila Silva Franco, et al.
Oncotarget|November 18, 2015
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)Carolina Terragna, Daniel Remondini, Marina Martello, et al.
British Journal of Haematology|January 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort studyMassimo Breccia, Valentina Giai, Tiziana Rosso, et al.
Blood|March 19, 2021
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myelomaAlessandra Larocca, Francesca Bonello, Gianluca Gaidano, et al.
Cytokine: X|February 19, 2021
Erratum to "Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by <i>Toxoplasma gondii</i> infection" [Cytokine: X 2 (2020) 100034]Camila Ferreira Marcon, Paula Tatiana Mutão Ferreira, Priscila Silva Franco, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Pregnant Women Chronically Infected by <i>Toxoplasma gondii</i> with Depressive Disorder: Differential Modulation of Pro-Inflammatory and Anti-Inflammatory CytokinesCarolina Salomão Lopes, Ricardo José Victal Carvalho, Tamires Lopes da Silva, et al.
Virus Research|December 24, 2022
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathwaysUriel Enrique Aquino Ruiz, Igor Andrade Santos, Victória Riquena Grosche, et al.
Blood|December 10, 2008
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di MidolloBenedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 PatientsGian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISAJames E Noble, Lili Wang, Eleonora Cerasoli, et al.
Pageof 102

Showing results (871-880 of 1,012) with videos related to

Sort By:
Pageof 102
Cytokine|September 18, 2020
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infectionCamila Ferreira Marcon, Paula Tatiana Mutão Ferreira, Priscila Silva Franco, et al.
Oncotarget|November 18, 2015
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)Carolina Terragna, Daniel Remondini, Marina Martello, et al.
British Journal of Haematology|January 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort studyMassimo Breccia, Valentina Giai, Tiziana Rosso, et al.
Blood|March 19, 2021
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myelomaAlessandra Larocca, Francesca Bonello, Gianluca Gaidano, et al.
Cytokine: X|February 19, 2021
Erratum to "Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by <i>Toxoplasma gondii</i> infection" [Cytokine: X 2 (2020) 100034]Camila Ferreira Marcon, Paula Tatiana Mutão Ferreira, Priscila Silva Franco, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Pregnant Women Chronically Infected by <i>Toxoplasma gondii</i> with Depressive Disorder: Differential Modulation of Pro-Inflammatory and Anti-Inflammatory CytokinesCarolina Salomão Lopes, Ricardo José Victal Carvalho, Tamires Lopes da Silva, et al.
Virus Research|December 24, 2022
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathwaysUriel Enrique Aquino Ruiz, Igor Andrade Santos, Victória Riquena Grosche, et al.
Blood|December 10, 2008
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di MidolloBenedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 PatientsGian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISAJames E Noble, Lili Wang, Eleonora Cerasoli, et al.
Pageof 102